About Definiens
Definiens is a company based in Munchen (Germany) founded in 1994 was acquired by MedImmune in November 2014.. Definiens has raised $33.25 million across 3 funding rounds from investors including European Union, MedImmune and TVM Capital Life Science. The company has 136 employees as of December 31, 2018. Definiens operates in a competitive market with competitors including PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.
- Headquarter Munchen, Germany
- Employees 136 as on 31 Dec, 2018
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$33.25 M (USD)
in 3 rounds
-
Latest Funding Round
$390.31 K (USD), Grant
Jan 05, 2015
-
Investors
European Union
& 5 more
-
Employee Count
136
as on Dec 31, 2018
-
Acquired by
MedImmune
(Nov 04, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Definiens
Definiens has successfully raised a total of $33.25M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $390.31 thousand completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $390,307
-
First Round
First Round
(01 Oct 2012)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2015 | Amount | Grant - Definiens | Valuation |
investors |
|
| Jun, 2014 | Amount | Series B - Definiens | Valuation | Wellington Partners Venture Capital , Gilde Healthcare | |
| Oct, 2012 | Amount | Series A - Definiens | Valuation | Gilde Healthcare |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Definiens
Definiens has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, MedImmune and TVM Capital Life Science. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Capital is invested in life science innovations for healthcare transformation.
|
Founded Year | Domain | Location | |
|
Investments are made in early-stage healthcare startups.
|
Founded Year | Domain | Location | |
|
Private equity and venture captial firm focused on healthcare sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Definiens
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Definiens
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Definiens Comparisons
Competitors of Definiens
Definiens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| domain | founded_year | HQ Location |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| domain | founded_year | HQ Location |
AI-powered single cell classification and isolation technology for clinical research
|
|
| domain | founded_year | HQ Location |
Digital pathology software is developed for clinical and veterinary productivity.
|
|
| domain | founded_year | HQ Location |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| domain | founded_year | HQ Location |
AI-based tools for pathological image analysis are provided to labs.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Definiens
Frequently Asked Questions about Definiens
When was Definiens founded?
Definiens was founded in 1994 and raised its 1st funding round 18 years after it was founded.
Where is Definiens located?
Definiens is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Is Definiens a funded company?
Definiens is a funded company, having raised a total of $33.25M across 3 funding rounds to date. The company's 1st funding round was a Series A of $12.85M, raised on Oct 01, 2012.
How many employees does Definiens have?
As of Dec 31, 2018, the latest employee count at Definiens is 136.
What does Definiens do?
Provides image analysis and data mining solutions for quantitative digital pathology in the healthcare industry. It offers Tissue Studio, a solution for biomarker and morphological profiling in research and drug discovery on tissue samples; and Developer XD, a solution for scientists image analysis experts to create and validate automated solutions for a range of biomedical image analysis problems. The company also provides Image Miner, a solution that integrates data mining with image analysis to accelerate biomarker research and development in life sciences. In addition, it focuses on supporting discovery, research, and diagnostics development that rely on the analysis of tissue samples; provides solutions for various phases of drug development. Further, the company supports clients in various stages of clinical development that include assay development, clinical validation, and test commercialization.
Who are the top competitors of Definiens?
Definiens's top competitors include Aignostics, Deciphex and Pictor Labs.
Who are Definiens's investors?
Definiens has 6 investors. Key investors include European Union, MedImmune, TVM Capital Life Science, Wellington Partners Venture Capital, and Cipio Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.